CTEPH patients had substantially higher costs and co-morbidity than matched controls, with circulatory-/respiratory-related costs accounting for 55% of excess costs. The high burden of illness suggests opportunities for savings from improved management. </AbstractSection> Copyright Adis Data Information BV 2011

Duloxetine treatment in CLBP patients/employees versus other non-surgical treatment was associated with reduced rates of non-surgical therapies and similar back surgery rates, without increased costs. </AbstractSection> Copyright Springer International Publishing AG 2012

<Emphasis Type="Bold">Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that often results in joint pain, inflammation and bone erosions. Perhaps the most notable change in RA treatment during the last decade is the advent of biologics, and, in particular, anti-tumour necrosis factor agents. Given...</emphasis>

<Emphasis Type="Bold">Background: Osteoporosis is a condition marked by low bone mineral density and the deterioration of bone tissue. One of the main clinical and economic consequences of osteoporosis is skeletal fractures. <Emphasis Type="Bold">Objective: To assess the healthcare and work loss costs of US patients with non-vertebral...</emphasis></emphasis>